Alzheimers
-
Business
Treating Alzheimer’s Very Early Offers Better Hope of Slowing Decline, Study Finds
A large study of experimental Alzheimer’s drugs, released Monday, suggests that treating Alzheimer’s patients as early as possible — when…
Read More » -
Business
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA
On Thursday, the Food and Drug Administration granted full approval of Lekhembi, a treatment for patients with early-stage Alzheimer’s disease,…
Read More » -
Health
FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
Food and Drug Administration on Thursday Full approval of Alzheimer’s disease drug Rekumbiand Medicare said it lays the groundwork for…
Read More » -
Health
Mutation Protected Man From Alzheimer’s Disease, Hinting at Treatment
news This man was supposed to have Alzheimer’s disease in his early 40s — he had, or seemed to have,…
Read More » -
Health
Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Drug maker Eli Lilly said Wednesday that an experimental Alzheimer’s drug in a clinical trial could slow the progression of…
Read More » -
Health
Trial of New Alzheimer’s Drug Reports Disappointing Results
Carefully watched clinical trials of potential Alzheimer’s disease medications have failed to prevent or delay cognitive decline. This is another…
Read More »